Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Planned sale · Filed 25/11/25

Trade details

Type: Planned sale notice
Stock: Nektar Therapeutics NKTR
Person: Howard W. RobinPresident & CEO
Planned sale date: 25/11/25
Filed: 25/11/25

More to sell after $787.4K in 3 months

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/26~25/12/25

Howard W. Robin's recent trades

Howard W. RobinPresident & CEO
Planned saleNektar Therapeutics
Planned sale
Nektar Therapeutics
NKTR
$30.1K
418 sh
$30.1K
Filed 08/18
Traded 08/18
Howard W. RobinPresident & CEO
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 plan
Nektar Therapeutics
NKTR
$334.5K
5,500 sh
$334.5K
Filed 06/18
Traded 06/17
Howard W. RobinPresident & CEO
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 plan
Nektar Therapeutics
NKTR
$318K
5,303 sh
$318K
Filed 06/18
Traded 06/16
Howard W. RobinPresident & CEO
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 plan
Nektar Therapeutics
NKTR
$285.2K
4,697 sh
$285.2K
Filed 06/18
Traded 06/16
Howard W. RobinPresident & CEO
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 plan
Nektar Therapeutics
NKTR
$277.4K
4,500 sh
$277.4K
Filed 06/18
Traded 06/17

Howard W. Robin, CEO — plans to sell 2,207 sh of Nektar Therapeutics NKTR · $129.8K · around 11/25 | Whalegun